NanoVibronix Stock Forecast, Price & News

+0.00 (+0.54 %)
(As of 04/16/2021 10:15 AM ET)
Today's Range
Now: $0.85
50-Day Range
MA: $1.07
52-Week Range
Now: $0.85
Volume1,811 shs
Average Volume3.85 million shs
Market Capitalization$11.45 million
P/E RatioN/A
Dividend YieldN/A
NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, India, and internationally. NanoVibronix, Inc. was founded in 2003 and is based in Elmsford, New York.
NanoVibronix logo

Industry, Sector and Symbol

Industry Surgical appliances & supplies
Current SymbolNASDAQ:NAOV
Year FoundedN/A



Sales & Book Value

Annual Sales$530,000.00
Book Value$0.30 per share


Net Income$-5,790,000.00
Net Margins-727.90%


Market Cap$11.45 million
Next Earnings Date7/5/2021 (Estimated)
OptionableNot Optionable


Form DEFA14A NanoVibronix, Inc. -
April 14, 2021 |
NanoVibronix Adjourns Special Meeting of Stockholders
March 31, 2021 |
NanoVibronix Regains Nasdaq Compliance - Business Wire
February 3, 2021 |
NanoVibronix Regains Nasdaq Compliance
February 3, 2021 |
NanoVibronix Issues Letter to Shareholders
January 19, 2021 |
See More Headlines


Overall MarketRank

0.53 out of 5 stars

Medical Sector

1503rd out of 2,021 stocks

Surgical Appliances & Supplies Industry

34th out of 40 stocks

Analyst Opinion: 0.0Community Rank: 2.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
+0.00 (+0.54 %)
(As of 04/16/2021 10:15 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive NAOV News and Ratings via Email

Sign-up to receive the latest news and ratings for NAOV and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

NanoVibronix (NASDAQ:NAOV) Frequently Asked Questions

What stocks does MarketBeat like better than NanoVibronix?

Wall Street analysts have given NanoVibronix a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but NanoVibronix wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting NanoVibronix?

NanoVibronix saw a decrease in short interest in March. As of March 31st, there was short interest totaling 161,300 shares, a decrease of 34.6% from the March 15th total of 246,700 shares. Based on an average daily volume of 4,080,000 shares, the days-to-cover ratio is currently 0.0 days.
View NanoVibronix's Short Interest

When is NanoVibronix's next earnings date?

NanoVibronix is scheduled to release its next quarterly earnings announcement on Monday, July 5th 2021.
View our earnings forecast for NanoVibronix

How were NanoVibronix's earnings last quarter?

NanoVibronix, Inc. (NASDAQ:NAOV) announced its quarterly earnings results on Wednesday, November, 14th. The company reported ($0.21) earnings per share for the quarter. The company earned $0.05 million during the quarter. NanoVibronix had a negative net margin of 727.90% and a negative trailing twelve-month return on equity of 418.55%.
View NanoVibronix's earnings history

How has NanoVibronix's stock price been impacted by COVID-19?

NanoVibronix's stock was trading at $2.75 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, NAOV stock has decreased by 68.9% and is now trading at $0.8547.
View which stocks have been most impacted by COVID-19

Who are NanoVibronix's key executives?

NanoVibronix's management team includes the following people:
  • Mr. Brian M. Murphy, CEO & Director (Age 64, Pay $288.23k)
  • Mr. Stephen R. Brown CPA, CPA, CFO & Accounting Officer (Age 65, Pay $180k)
  • Mr. Amir Rippel, VP of Marketing
  • Mrs. Lindsey Harrison, VP of Sales
  • Dr. Harold Jacob, Chief Medical Officer & Director (Age 67)

Who are some of NanoVibronix's key competitors?

What other stocks do shareholders of NanoVibronix own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NanoVibronix investors own include T2 Biosystems (TTOO), ADMA Biologics (ADMA), (CGC), Co-Diagnostics (CODX), Inovio Pharmaceuticals (INO), Tonix Pharmaceuticals (TNXP), BIO-key International (BKYI), Digital Ally (DGLY), iBio (IBIO) and Inpixon (INPX).

What is NanoVibronix's stock symbol?

NanoVibronix trades on the NASDAQ under the ticker symbol "NAOV."

How do I buy shares of NanoVibronix?

Shares of NAOV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is NanoVibronix's stock price today?

One share of NAOV stock can currently be purchased for approximately $0.85.

How much money does NanoVibronix make?

NanoVibronix has a market capitalization of $11.45 million and generates $530,000.00 in revenue each year. The company earns $-5,790,000.00 in net income (profit) each year or ($0.83) on an earnings per share basis.

How many employees does NanoVibronix have?

NanoVibronix employs 10 workers across the globe.

What is NanoVibronix's official website?

The official website for NanoVibronix is

Where are NanoVibronix's headquarters?

NanoVibronix is headquartered at 525 Executive Blvd, Elmsford NY, 10523.

How can I contact NanoVibronix?

NanoVibronix's mailing address is 525 Executive Blvd, Elmsford NY, 10523. The company can be reached via phone at 914-233-3004 or via email at [email protected]

This page was last updated on 4/16/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.